BioSyent Inc. (OTCMKTS:BIOYF – Get Free Report) saw a large increase in short interest in October. As of October 31st, there was short interest totalling 1,300 shares, an increase of 18.2% from the October 15th total of 1,100 shares. Based on an average daily trading volume, of 1,700 shares, the days-to-cover ratio is currently 0.8 days.
BioSyent Price Performance
OTCMKTS:BIOYF opened at $7.83 on Friday. The company has a 50-day moving average of $8.00 and a 200-day moving average of $7.44. BioSyent has a 52 week low of $5.86 and a 52 week high of $8.90.
BioSyent Increases Dividend
The firm also recently declared a dividend, which was paid on Sunday, September 15th. Shareholders of record on Thursday, September 5th were paid a dividend of $0.0334 per share. This is a boost from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a yield of 1.72%.
About BioSyent
BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.
Recommended Stories
- Five stocks we like better than BioSyent
- 3 Stocks to Consider Buying in October
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- What Are Dividend Achievers? An Introduction
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- The How and Why of Investing in Gold Stocks
- Time to Load Up on Home Builders?
Receive News & Ratings for BioSyent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSyent and related companies with MarketBeat.com's FREE daily email newsletter.